Attachment IV - Ffcge 1 
ACRONYMS 
AAV 
adeno-associated virus 
ACV 
acyclovir 
ADA 
adenosine deaminase 
ADD 
adenosine deaminase deficiency 
AIDS 
acquired immune deficiency syndrome 
BL 
biosafety level 
BMT 
bone marrow transplantation 
cDNA 
complementary DNA 
CF 
cystic fibrosis 
CFR 
Code of Federal Regulations 
CFTR 
cystic fibrosis transmembrane conductance regulator 
cm 
centimeter 
CMV 
cytomegalovirus 
CSF 
cerebral spinal fluid 
CTL 
cytotoxic T lymphocyte 
DNA 
deoxyribonucleic acid 
FDA 
Food and Drug Administration 
FIAU 
fialuridine 
GCV 
ganciclovir 
HIV 
human immunodeficiency virus 
HSV-TK 
herpes simplex virus thymidine kinase 
IBC 
Institutional Biosafety Committee 
IDS 
iduronate-2-sulfatase 
IL 
interleukin 
IND 
Investigational New Drug Application 
IRB 
Institutional Review Board 
ITR 
inverted terminal repeats 
kd 
kilodalton 
LTR 
long terminal repeat 
ml 
milliliter 
mg 
milligram 
MHC 
major histocompatibility complex 
MMTV 
mouse mammary tumor virus 
MOI 
multiplicity of infections 
MRI 
magnetic resonance imaging 
mRNA 
messenger ribonucleic acid 
neo R 
neomycin resistance 
NIH 
National Institutes of Health 
NIH Guidelines 
NIH Guidelines for Research Involving Recombinant DNA Molecules 
PAD 
peripheral artery disease 
ORDA 
Office of Recombinant DNA Activities 
PCR 
polymerase chain reaction 
PET 
positron emission tomography 
PFU 
plaque forming units 
PI 
principal investigator 
Recombinant DNA Research, Volume 20 
[107] 
